Page last updated: 2024-08-26

mizoribine and Glomerulonephritis, Minimal Change

mizoribine has been researched along with Glomerulonephritis, Minimal Change in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manabe, S; Nagata, M; Nitta, K1
Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y1
Cho, BS; Hahn, WH; Kim, SD; Park, SS1
Hirayama, K; Kobayashi, M1
Fujita, S; Iharada, A; Kaneko, K; Miyazaki, K; Okada, M; Sakata, N; Sugimoto, K; Takemura, T; Tsuji, S; Yanagida, H1
Akashi, S; Fujinaga, S; Kaneko, K; Murakami, H; Ohtomo, Y; Shimizu, T; Takada, M; Yamashiro, Y1
Gomi, H; Ishimoto, F; Matsuda, H; Sakai, O; Shibasaki, T; Usui, M1

Reviews

2 review(s) available for mizoribine and Glomerulonephritis, Minimal Change

ArticleYear
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
    Contributions to nephrology, 2018, Volume: 195

    Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases

2018
[Minimal change nephrotic syndrome].
    Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:7

    Topics: Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrosis, Lipoid; Prednisolone; Proteinuria; Pulse Therapy, Drug; Ribonucleosides

2010

Other Studies

5 other study(ies) available for mizoribine and Glomerulonephritis, Minimal Change

ArticleYear
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Clinical and experimental nephrology, 2015, Volume: 19, Issue:3

    Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome

2015
Remission of refractory minimal change nephrotic syndrome after basiliximab therapy.
    Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:7

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Basiliximab; Child, Preschool; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Nephrosis, Lipoid; Recombinant Fusion Proteins; Ribonucleosides

2009
GSTT1 gene abnormality in minimal change nephrotic syndrome with elevated serum immunoglobulin E.
    Clinical nephrology, 2012, Volume: 77, Issue:4

    Topics: Adolescent; Biomarkers; Biopsy; Child; Comparative Genomic Hybridization; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Glutathione Transferase; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Mutation; Nephrosis, Lipoid; Polymerase Chain Reaction; Proteinuria; Reactive Oxygen Species; Ribonucleosides; T-Lymphocytes, Helper-Inducer; Treatment Outcome

2012
High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
    Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:12

    Topics: Adolescent; Adult; Age of Onset; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Ribonucleosides; Secondary Prevention; Time Factors; Treatment Outcome

2005
Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
    American journal of nephrology, 1996, Volume: 16, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Immunosuppressive Agents; Male; Nephrosis; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Ribonucleosides; Thromboxane B2

1996